Roche Highlights its Response to COVID-19 Pandemic
Shots:
- On Mar 19- 2020- the company initiates the global P-III study in collaboration with BARDA to assess the efficacy of Actemra/RoActemra (tocilizumab- IV) + SOC vs PBO + SOC in hospitalized patients with severe COVID-19 pneumonia
- Roche facilitates the delivery and production of Actemra and is working continuously to increase the availability of COVID 19-tests as its test has received FDA’s EUA for its SARS-CoV-2 test
- Roche is working with governments across the globe to work closely with industry to keep manufacturing and supply running to tackle the pandemic
Click here to read full press release/ article
Ref: Roche | Image: Roche
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com